2026-04-28T19:17:38Zhttps://uvadoc.uva.es/oai/requestoai:uvadoc.uva.es:10324/58102025-02-26T10:17:21Zcom_10324_1179com_10324_931com_10324_894col_10324_1306
Pérez Castrillon, José Luis
Silva, Jesús
Justo, Isabel
Sanz Cantalapiedra, Alberto
Martín-Luquero Ibáñez, Miguel
Igea, Rosa
Escudero, Pilar
Pueyo, Carol
Díaz, Cristina
Hernández, Gonzalo
Dueñas Laita, Antonio
2003
Producción Científica
Background: Many alterations in extracellular metabolism
of calcium have been associated to hypertension, but
the number of studies relating this disease with osteoporosis
is extremely low. This study clarifies the therapeutic
effect of three treatments— quinapril, quinapril hydrochlorothiazide
(HCTZ), enalapril—on bone remodeling
markers, bone mineral density (BMD) in hypertensive
patients, and relationship with angiotensin converting enzyme
(ACE) polymorphism.
application/pdf
http://uvadoc.uva.es/handle/10324/5810
eng
Elsevier
Hipertension arterial - Tratamiento
Effect of quinapril, quinapril-hydrochlorothiazide, and enalapril on the bone mass of hypertensive subjects: relationship with angiotensin converting enzyme polymorphisms
info:eu-repo/semantics/article
TEXT
UVaDOC. Repositorio Documental de la Universidad de Valladolid
Hispana